US Patent 7932290 Method for the treatment of metabolic disorders
Patent 7932290 was granted and assigned to Wellstat Biologics Corporation on April, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+233 characters)
Article
Patent abstract
Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07932290 Method for the treatment of metabolic disorders US Patent 7932290 Method for the treatment of metabolic disorders
Infobox
Patent Number
0793229000
Patent Number
793229000
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079322900
Date of Patent
April 26, 2011
0Patent Application Number
125504820
Date Filed
August 31, 2009
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079322900
Date of Patent
April 26, 2011
0Patent Application Number
125504820
Date Filed
August 31, 2009
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07932290 Method for the treatment of metabolic disorders
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07932290
Date of patent
April 26, 2011
Patent application number
12550482
Date Filed
August 31, 2009
Patent primary examiner
Find more entities like US Patent 7932290 Method for the treatment of metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
